Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- TOUR +1.8%
M&A news:
- MGCD +24.4% (Altus will acquire all outstanding shares of MGCD for $11.03/share in cash)
- TIME +8.9% (to be acquired by Meredith Corp (MDP) for $18.50 per share), MDP +4.8%
- CLNE +3.3% (Clean Energy Fuels and and Landi Renzo 'are combining their compressor manufacturing subsidiaries to form a new standalone company'), .
Other news:
- SSC +43% (cont strength, closed 26% higher on Friday, trading higher with Bitcoin nearling $10,000)
- MARA +29.4% (Cryptocurrency play MARA extends this week's break out to multi-month high)
- CPRX +8% (reports 'positive' top-line results from a second Phase 3 clinical trial (LMS-003) of Firdapse)
- RYB +6.6% (provides update: Police report indicates one teacher was detained for maltreatment of students; another fabricated info about child abuse)
- UEPS +5.1% (continued stre ngth, +20.5% last week)
- MDGS +3% (modestly rebounding following Friday's offering)
- DRYS +2.8% (continued volatility in pre-mkt)
- ALKS +2.4% (Alkermes and Biogen (BIIB) enter a global license and collaboration agreement to develop and commercialize ALKS 8700)
- SHOP +1.7% (reports Black Friday sales exceeded $1 mln per minute at peak time)
Analyst comments:
- ARWR +4.6% (upgraded to Overweight from Neutral at Piper Jaffray)
- ROKU +4.1% (target raised to $50 at Needham)
- SPRO +3.9% (initiated with a Buy at Stifel; tgt $26 (closed at 13.86 on Friday))
- CIEN +3.3% (upgraded to Buy from Neutral at BofA/Merrill)
- GSK +2.4% (upgraded to Buy from Neutral at UBS)
- FNKO +2% (initiated with a Buy at Goldman; initiated with a Overweight at JP Morgan)
- SBS +1.3% (upgraded to Overweight from Neutral at JP Morgan)
- NGG +1.1% (upgraded to Neutral from Underperform at Credit Suisse)